In this conversation, Kaushik Trivedi interviews Professor Andrew Beggs, a pioneering figure in cancer genetics and surgery. They discuss the traditional approaches to cancer treatment and how Andrew's dual role as a surgeon and scientist allows him to bridge the gap between immediate patient care and long-term research. Andrew shares his personal journey, including moments of self-doubt, the emotional challenges of balancing surgery and research, and the sacrifices made in pursuit of excellence. The conversation also touches on the evolution of cancer understanding, the importance of collaboration in research, and the future of cancer treatment through genomics and immunotherapy. In this conversation, Andrew Beggs discusses the transformative potential of liquid biopsies, advancements in precision therapy, and the future of organoid technology in cancer treatment. He highlights the challenges in organoid culture and the revolutionary impact of long-read genomic sequencing. The discussion also covers the role of AI in cancer diagnostics, the emerging innovation hub in the West Midlands, and the barriers to biotech advancement in the UK. Finally, they touch on the significance of Life Sciences Week as a platform for fostering collaboration and innovation in the healthcare sector.

Exclusive Access: Life Sciences Week 2026 (#LSW26)!We are thrilled to announce that Drug Diaries is partnering with Life Sciences Week 2026 (21–25 September 2026), the UK’s premier gathering for biotech, pharma, med-tech, AI, and healthcare policy leaders!

Join 3,000+ industry pioneers, policymakers, and investors as we dive deep into the future of healthcare innovation.

Seats are filling fast—secure your spot today with our exclusive community discount! 🎟️ Register Now:

https://lifesciencesweek.co.uk/attend/

⚡ Exclusive Discount Code: DRUGDIARIES10 (Use at checkout for an exclusive discount!)Don't wait—claim your ticket now and be part of the national conversation shaping life sciences!

Chapters 00:00 Introduction to Andrew Beggs and his dual role in surgery and science 02:44 Andrew's motivation for combining surgery with genomics research 04:23 Early influences and the evolution of Andrew’s career 06:31 Overcoming self-doubt and career setbacks 09:48 Spark for cancer genetics and core beliefs changed 12:24 Handling emotional challenges of patient outcomes 14:29 Balancing clinical intensity with scientific research 16:01 Personal sacrifices and leadership in high-stakes environments 17:17 Lessons on leading multidisciplinary teams 21:19 Explaining cancer heterogeneity to a child 22:38 Progress in cancer genomics and immunotherapy 24:06 Liquid biopsy and its revolutionary potential 27:25 Organoids and personalized drug testing 34:48 Advances in long-read sequencing technology 37:50 AI in cancer diagnostics and research 40:48 Predicting immune responses with AI and genomics 42:22 West Midlands as a biotech innovation hub 47:43 Future of cancer treatment and diagnostic breakthroughs in 10 years Get vidIQ to grow your channel faster! 🚀 https://vidiq.com/DrugDiaries

How one pharmaceutical development project generated 50 billion dollars despite management trying to kill it. See the high-stakes reality.

In this episode, Dr. David Brown shares his 52-year journey in drug discovery, the transformative potential of AI in medicine, and the urgent need for the pharmaceutical industry to embrace paradigm shifts to reduce human suffering.

You will hear the inside perspective of a clinical development committee meeting where the project was faced with a three-month deadline to prove efficacy or face total termination. This is for anyone interested in the friction between medical research and corporate budget constraints.

Learn how drug discovery survives when budgets are cut to zero and leadership demands immediate results. We examine the tension of professional life when your career hinges on proving the viability of a vital medical treatment. Understand the pressure of navigating complex clinical trials while your own company actively attempts to shut you down.

Subscribe for weekly career breakdowns and tell me, have you ever had to fight for a project you believed in against all odds?

Chapters

0:00 The $50 Billion Discovery That Almost Never Was

5:05 From Punch Cards to AI-Driven Medicine

9:10 Why AI Must Be the Foundation, Not a Bolt-On

14:07 The Stagnation of Big Pharma's Financial Engine

18:06 The 90-Day Thread: A Project Hanging by a Wire

25:03 The Lightbulb Moment: Connecting the Dots

35:55 Navigating Power Plays in Legacy Organizations

42:21 Mapping Mountains and Valleys with AI

Get vidIQ to grow your channel faster! 🚀

https://vidiq.com/DrugDiaries

In this episode, Kaushik Trivedi interviews Professor Neil Hanley about the transformative healthcare innovations happening in the West Midlands, UK. They explore regional collaboration, cutting-edge research, and the future of data-driven medicine.

As a thank you to the Drug Diaries Podcast community, I am pleased to share an exclusive 10% discount for Life Sciences Week 2026. Use code: DRUGDIARIES10

https://lifesciencesweek.co.uk/conference-launch-tickets/

Chapters

00:00 Introduction to the West Midlands healthcare revolution

01:19 Neil Hanley's role in shaping UK health innovation

03:10 Neil Hanley's early career and scientific inspiration

11:13 The concept of the golden parallelogram in UK science

14:41 The strategic importance of Birmingham's diverse healthcare ecosystem

20:58 The Birmingham Health Innovation Campus and its facilities

25:31 Co-locating startups, scientists, and healthcare providers

32:44 Data-driven healthcare and AI in preventative medicine

38:44 Future directions in aging, longevity, and gene therapy

48:53 Neil Hanley's legacy and vision for Birmingham

Get vidIQ to grow your channel faster! 🚀 https://vidiq.com/DrugDiaries